Concise Analysis of the International Orphan Drugs Industry
DUBLIN, Mar. 13, 2014 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/fzkt7z/orphan_drugs) has announced the addition of the "Concise Analysis of the International Orphan Drugs Industry " report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769)
This report analyzes the worldwide markets for Orphan Drugs in US$ Million. The report provides separate comprehensive analytics for the US, Europe, Japan, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.
The report profiles 113 companies including many key and niche players such as:
- AbbVie Inc.
- Actelion Pharmaceuticals Ltd.
- Amgen Inc.
- AstraZeneca plc
- Bayer HealthCare AG
- Biogen Idec Inc.
- Bristol-Myers Squibb Company
- Boehringer Ingelheim GmbH
- Celgene Corporation
- CEL-SCI Corporation
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck & Co. Inc.
- Merck Serono International S.A.
- Novartis AG
- Pfizer Inc.
- Recordati S.p.A.
- Orphan Europe
- Sanofi SA
- Genzyme Corporation.
Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.
For information on site licence pricing please click on Enquire before buying.
Key Topics Covered:
I. Introduction, Methodology & Product Definitions
II. Executive Summary
1. Industry Overview
2. Growth Drivers And Inhibitors
3. Challenges To Orphan Drug Development
4. Current Market Trends
5. Breakthroughs In Orphan Disease Treatment - A Ray Of Hope
6. Regulatory Scenario
7. Product Overview
8. Recent Orphan Designations & Approvals
9. Recent Industry Activity
10. Focus On Select Players
11. Global Market Perspective
III. Market
1. The United States
2. Japan
3. Europe
4. Rest Of World
IV. Competitive Landscape
Total Companies Profiled: 113 (including Divisions/Subsidiaries - 121)
- The United States (61)
- Canada (4)
- Japan (9)
- Europe (42)
- France (8)
- Germany (3)
- The United Kingdom (4)
- Italy (4)
- Rest of Europe (23)
- Asia-Pacific (Excluding Japan) (3)
- Middle East (2)
For more information visit http://www.researchandmarkets.com/research/fzkt7z/orphan_drugs
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article